{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:43:06Z","timestamp":1788183786858,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R42AI155039-02"],"award-info":[{"award-number":["R42AI155039-02"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejmech.2025.117679","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T02:26:57Z","timestamp":1745634417000},"page":"117679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses"],"prefix":"10.1016","volume":"292","author":[{"given":"Malaika D.","family":"Argade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varada","family":"Anirudhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Tomorowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Bott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boopathi","family":"Sownthirarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan S.","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsen M.","family":"Gaisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry W.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Manicassamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norton P.","family":"Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8668-3222","authenticated-orcid":false,"given":"Irina N.","family":"Gaisina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117679_bib1","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A brief review of influenza virus infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejmech.2025.117679_bib2","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117679_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","article-title":"Influenza","volume":"390","author":"Paules","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117679_bib4","unstructured":"N.M. Bouvier, P. Palese, The Biology of Influenza Viruses, n.d."},{"key":"10.1016\/j.ejmech.2025.117679_bib5","series-title":"Influenza (Seasonal)","year":"2023"},{"key":"10.1016\/j.ejmech.2025.117679_bib6","series-title":"Types of Influenza Viruses","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117679_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/hs.2017.0038","article-title":"Global catastrophic biological risks: toward a working definition","volume":"15","author":"Schoch-Spana","year":"2017","journal-title":"Health Secur"},{"key":"10.1016\/j.ejmech.2025.117679_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ph14060587","article-title":"Small molecule inhibitors of influenza virus entry","volume":"14","author":"Chen","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117679_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens5040066","article-title":"Reviewing the history of pandemic influenza: understanding patterns of emergence and transmission","volume":"5","author":"Saunders-Hastings","year":"2016","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2025.117679_bib10","doi-asserted-by":"crossref","first-page":"20248","DOI":"10.1073\/pnas.1320524110","article-title":"Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins","volume":"110","author":"Heaton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117679_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081650","article-title":"Evolution of influenza A virus by mutation and Re-Assortment","volume":"18","author":"Shao","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117679_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038489","article-title":"The ecology and evolution of influenza viruses","volume":"10","author":"Wille","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ejmech.2025.117679_bib13","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2025.117679_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100452","article-title":"Outlining recent updates on influenza therapeutics and vaccines: a comprehensive review","volume":"17","author":"Malik","year":"2024","journal-title":"Vaccine X"},{"key":"10.1016\/j.ejmech.2025.117679_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.antiviral.2013.08.023","article-title":"Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance","volume":"100","author":"Burnham","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117679_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116172","article-title":"Tackling Influenza A virus by M2 ion channel blockers: latest progress and limitations","volume":"267","author":"Kumar","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117679_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105631","article-title":"Clinical outcomes and plasma concentrations of Baloxavir Marboxil and favipiravir in COVID-19 patients: an exploratory randomized, controlled trial","volume":"157","author":"Lou","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.117679_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00154-23","article-title":"Impact of Baloxavir resistance-associated substitutions on influenza virus growth and drug susceptibility","volume":"97","author":"Hickerson","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2025.117679_bib19","series-title":"Factsheet on A(H5N1), European Centre for Disease Prevention and Control","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117679_bib20","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1021\/acs.jmedchem.3c01715","article-title":"Discovery of a macrocyclic influenza cap-dependent endonuclease inhibitor","volume":"67","author":"Feng","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117679_bib21","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jiy547","article-title":"Phase 2b study of Pimodivir (JNJ-63623872) as monotherapy or in combination with Oseltamivir for treatment of acute uncomplicated seasonal influenza A: TOPAZ trial","volume":"219","author":"Finberg","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117679_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/infdis\/jiaa376","article-title":"A phase 2 study of Pimodivir (JNJ-63623872) in combination with Oseltamivir in elderly and nonelderly adults hospitalized with influenza A infection: OPAL study","volume":"226","author":"O'Neil","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117679_bib23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038638","article-title":"Hemagglutinin structure and activities","volume":"11","author":"Gamblin","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ejmech.2025.117679_bib24","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1021\/acs.jmedchem.9b01900","article-title":"Optimization of 4-Aminopiperidines as inhibitors of influenza A viral entry that are synergistic with Oseltamivir","volume":"63","author":"Gaisina","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117679_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk9004","article-title":"An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil","volume":"10","author":"Gaisina","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.117679_bib26","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1021\/acs.jmedchem.2c01329","article-title":"Synthesis, optimization, and structure-activity relationships of Imidazo[1,2-a]pyrimidines as inhibitors of group 2 influenza A viruses","volume":"65","author":"Alqarni","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117679_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105013","article-title":"Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins","volume":"186","author":"Du","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117679_bib28","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000724","article-title":"Structure of avian influenza hemagglutinin in complex with a small molecule entry inhibitor","volume":"3","author":"Antanasijevic","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.ejmech.2025.117679_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1087057113494405","article-title":"A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses","volume":"19","author":"Wang","year":"2014","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2025.117679_bib30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.tetlet.2005.11.152","article-title":"Multi-component reactions between 2-aminopyrimidine, aldehydes and isonitriles: the use of a nonpolar solvent suppresses formation of multiple products","volume":"47","author":"Parchinsky","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117679_bib31","author":"Smith","year":"2007","journal-title":"PI-3 KINASE INHIBITORS AND METHODS OF THEIR USE"},{"key":"10.1016\/j.ejmech.2025.117679_bib32","article-title":"From bench to bedside: what do we know about imidazothiazole derivatives So far?","volume":"28","author":"Guo","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117679_bib33","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117679_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117679_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.117679_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad577","article-title":"Evolution of influenza A(H3N2) viruses in 2 consecutive seasons of genomic surveillance, 2021\u20132023","volume":"10","author":"Fall","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117679_bib37","article-title":"The H4 subtype of avian influenza virus: a review of its historical evolution, global distribution, adaptive mutations and receptor binding properties","volume":"103","author":"Liu","year":"2024","journal-title":"Poult. Sci."},{"key":"10.1016\/j.ejmech.2025.117679_bib38","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.tetlet.2006.11.181","article-title":"Regioselective two step synthesis of 3-substituted 2-aminoimidazo[1,2-a]pyrimidines","volume":"48","author":"Carballares","year":"2007","journal-title":"Tetrahedron Lett."}],"updated-by":[{"DOI":"10.1016\/j.ejmech.2025.117766","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000}}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T08:48:21Z","timestamp":1753865301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425004441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"alternative-id":["S0223523425004441"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117679","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ejmech.2025.117766","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117679"}}